DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Real-time price. Currency in USD

DarioHealth Corp.

18 West 18th Street
New York, NY 10011
United States
347 767 4220

IndustryDiagnostics & Research
Full-time employees241

Key executives

NameTitlePayExercisedYear born
Mr. Erez RaphaelCEO & Director978.76kN/A1973
Mr. Richard A. AndersonPres998.42kN/A1969
Mr. Zvi Ben DavidCFO, Treasurer & Sec.429.05kN/A1961
Dov OppenheimCo-Founder & Production ChiefN/AN/AN/A
Josh FischerSr. VP of Operations & ComplianceN/AN/AN/A
Claudia LeviContent & Communications Mang.N/AN/AN/A
Mary MooneyVP of MarketingN/AN/AN/A
Limor DreznerVP HR & Chief of StaffN/AN/AN/A
Mr. Olivier R. JarrySr. VP of Strategy & Bus. Devel.N/AN/A1961
Mr. Jean Christophe MuylHead of Commercialization North AmericaN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Corporate governance

DarioHealth Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.